Paper40134771
A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.
Rostami M and 7 others. Front Bioeng Biotechnol, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities. Papers, record 40134771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40134771
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37322139 | Electrospun nanofiber membrane diameter prediction using a combined response surface methodology and machine learning approach. | Sci Rep | 2023 | https://conductscience.org/library/papers/37322139 | PubMed |
| 2 | 36948284 | Doxorubicin-loaded micelles in tumor cell-specific chemotherapy. | Environ Res | 2023 | https://conductscience.org/library/papers/36948284 | PubMed |
| 3 | 26306537 | Antitumor Activity of Doxorubicin-Loaded Carbon Nanotubes Incorporated Poly(Lactic-Co-Glycolic Acid) Electrospun Composite Nanofibers. | Nanoscale Res Lett | 2015 | https://conductscience.org/library/papers/26306537 | PubMed |
| 4 | 32260617 | Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers. | J Mater Chem B | 2013 | https://conductscience.org/library/papers/32260617 | PubMed |
| 5 | 25579518 | An overview of doxorubicin formulations in cancer therapy. | J Cancer Res Ther | 2014 | https://conductscience.org/library/papers/25579518 | PubMed |
| 6 | 34078252 | Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. | J Biomater Sci Polym Ed | 2021 | https://conductscience.org/library/papers/34078252 | PubMed |
| 7 | 39014260 | Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates. | Protein J | 2024 | https://conductscience.org/library/papers/39014260 | PubMed |
| 8 | 34636282 | Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy. | Expert Rev Anticancer Ther | 2021 | https://conductscience.org/library/papers/34636282 | PubMed |
| 9 | 32805104 | Harnessing a Novel Machine-Learning-Assisted Evolutionary Algorithm to Co-optimize Three Characteristics of an Electrospun Oil Sorbent. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32805104 | PubMed |
| 10 | 39495464 | Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity. | Cardiovasc Toxicol | 2025 | https://conductscience.org/library/papers/39495464 | PubMed |
| 11 | 37977290 | Incorporation of doxorubicin and CoFe2O4 nanoparticles into the cellulose acetate phthalate / polyvinyl alcohol (core)/ polyurethane (shell) nanofibers against A549 human lung cancer during chemotherapy/hyperthermia combined method. | Int J Pharm | 2024 | https://conductscience.org/library/papers/37977290 | PubMed |
| 12 | 35283223 | Artificial intelligence to bring nanomedicine to life. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35283223 | PubMed |
| 13 | 36103274 | Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia. | ACS Biomater Sci Eng | 2022 | https://conductscience.org/library/papers/36103274 | PubMed |
| 14 | 34585584 | Dynamic Pore Modulation of Stretchable Electrospun Nanofiber Filter for Adaptive Machine Learned Respiratory Protection. | ACS Nano | 2021 | https://conductscience.org/library/papers/34585584 | PubMed |
| 15 | 35360005 | Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/35360005 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42020465 | Predictive modeling of controlled drug release from polysaccharide-based systems using gradient boosting and metaheuristic optimization. | Sci Rep | 2026 | https://conductscience.org/library/papers/42020465 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40134771
GET https://conductscience.org/api/papers/v1/40134771/authors